Sonoma Pharmaceuticals SNOA
NASDAQ SNOA
$1.23 -0.02 (-2.00%)
As of: Oct 2, 2026 · 1:04 PM EDT

Sonoma Pharmaceuticals (SNOA) Non-Current Deffered Revenue (2011 - 2025)

Updated

Sonoma Pharmaceuticals (SNOA) posted Non-Current Deffered Revenue of $4,000 for fiscal Q1 2026 (quarter ended Jun 30, 2025), down 93.8% from $64,000 a year earlier and down 76.5% from the prior quarter.

Analysis

Sonoma Pharmaceuticals (SNOA) Non-Current Deffered Revenue (2011 - 2025) Analysis & Trends

At the end of FY2025 (ended Mar 31, 2025), Sonoma Pharmaceuticals' Non-Current Deffered Revenue came in at $17,000, down 80.5% from FY2024.

  • Annual Non-Current Deffered Revenue has declined for eight consecutive fiscal years, with a five-year compound annual growth rate of -41.4% (FY2020 to FY2025).
  • In prior fiscal years, Sonoma Pharmaceuticals' Non-Current Deffered Revenue was $87,000 in FY2024 (-37.9%), $140,000 in FY2023 (-23.1%), $182,000 in FY2022 (-20.5%) and $229,000 in FY2021 (-6.5%).
  • The fiscal Q1 2026 figure stands as the lowest quarterly Non-Current Deffered Revenue in data going back to fiscal Q4 2011.
  • On a year-over-year basis, Non-Current Deffered Revenue has declined in each of the last 31 quarters, with an average decline of 54.1% over the last eight quarters.
  • The year-over-year decline in Non-Current Deffered Revenue has ranged between 6.3% (fiscal Q1 2022) and 93.8% (fiscal Q1 2026) over the last five years.
  • According to Business Quant data, Non-Current Deffered Revenue for the three prior fiscal quarters was $17,000 (Q4 2025), $30,000 (Q3 2025) and $45,000 (Q2 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Thermo Fisher Scientific 249.71 Bn 228.86 Bn 4.88 Bn -
2 Abbott Laboratories 171.00 Bn 142.08 Bn 7.27 Bn -
3 Danaher 155.79 Bn 139.61 Bn 3.61 Bn -
4 Intuitive Surgical 143.91 Bn 123.46 Bn 1.96 Bn -
5 Medtronic 110.42 Bn 76.29 Bn 6.34 Bn -
6 Stryker 105.71 Bn 91.82 Bn 4.50 Bn -
7 Boston Scientific 63.26 Bn 58.27 Bn 3.85 Bn -
8 Edwards Lifesciences 49.80 Bn 33.91 Bn 1.35 Bn -
9 Becton Dickinson 48.78 Bn 45.93 Bn 2.32 Bn -
10 Sonoma Pharmaceuticals 4.92 Mn -8.41 Mn 2.58 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 4,000.00
Mar 31, 2025 17,000.00
Dec 31, 2024 30,000.00
Sep 30, 2024 45,000.00
Jun 30, 2024 64,000.00
Mar 31, 2024 87,000.00
Dec 31, 2023 101,000.00
Sep 30, 2023 114,000.00
Jun 30, 2023 132,000.00
Mar 31, 2023 140,000.00
Dec 31, 2022 128,000.00
Sep 30, 2022 138,000.00
Jun 30, 2022 152,000.00
Mar 31, 2022 182,000.00
Dec 31, 2021 190,000.00
Sep 30, 2021 205,000.00
Jun 30, 2021 225,000.00
Mar 31, 2021 229,000.00
Dec 31, 2020 251,000.00
Sep 30, 2020 235,000.00
API Access

Sonoma Pharmaceuticals Non-Current Deffered Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=SNOA&period=max&api_key=YOUR_API_KEY